Albumin and the Zinc Switch

Y Coleman,

17th June 2025
The zinc switch is dependent upon albumin availability from MedNut Mail post The Zinc Switch

The zinc switch is an excellent example of an albumin-based drug-nutrient interaction mechanism.  

Takeaways 

Albumin is zinc's primary carrier.

The zinc switch is a critical drug-nutrient interaction that is particularly vulnerable to disruption.

Interference with the zinc switch has profound downstream implications.

The Zinc Switch  

Essentially the zinc switch is the occupancy or allosteric change to FA2 binding sites causing zinc exclusion from MBS-A. Zinc exclusion includes both eviction from and inhibited uptake by MBS-A. MBS-A is also known as Multi-metal Binding Site A, Site A, Cadmium site A.

The zinc switch is located in the domain I/II interface on albumin.

FA2 (Fatty Acid Binding Site 2)

FA2 is located in the domain I/II interface, and overlaps the MBS-A site.

Albumin is the primary carrier for NEFAs (non-esterified fatty acids) which are free (unbound), typically long chain fatty acids such as palmitate and stearate. Fatty acid carbon chain length and saturation inversely correlate with zinc binding to MBS-A.

FA1, FA2 and FA7 are functionally and allosterically. Consequently, binding on one site is likely to alter binding capabilities (competitive and/or allosteric) of the other two sites.

Drugs that bind to -

  - FA2 include – cannabis (primary binding site), ibuprofen (tertiary binding site), warfarin (tertiary binding site);

  - FA1 include - rifampicin, isoniazid, fipronil;

  - FA7 include – azapropazone, diclofenac, diflunisal, gemfibrozil, ibuprofen, indomethacin, phenylbutazone, tolbutamide, warfarin.

As fatty acid levels increase FA2 occupancy, zinc binding capacity to albumin decreases.

Zinc

Albumin regulates zinc levels by being both its buffer/chelator and a systemic (throughout the body) transporter.

Zinc’s binding sites on albumin include –

   - primary – MBS-A,

   - secondary – MBS-B,

   - tertiary – currently 6 known sites.

The alternate sites (secondary, tertiary) extend zinc’s binding capacity when zinc levels are elevated or MBS-A binding is compromised.

Zinc binding to albumin is dependent upon the concentration of free zinc (zinc ions) in the blood. Increasing free zinc levels means decreasing zinc binding capacity to albumin.

The main consequences of an increase in free zinc levels in blood include –

1) redistribution of zinc to other plasma proteins such as insulin and HRG (histidine-rich glycoprotein),

2) removal of zinc from the plasma.

Excessive free zinc levels in the plasma are toxic.

Albumin and Insulin 

Insulin is released from the pancreas into the plasma as a hexamer comprising 6 insulins bound by 2 zincs. The release of zinc from hexamers produces insulin monomers and oligomers (dimers, trimers, tetramers, hexamers). Only insulin monomers are biologically active.

Plasma levels of monomers and oligomers are fluid and indicate zinc’s addition or removal from the oligomers. Insulin fluidity is typically influenced by environmental factors such plasma zinc levels. As zinc levels increase, the levels of oligomers increase via a monomer-dimer-tetramer-hexamer equilibrium.

Proposed mechanism for the cleaving of zinc from insulin in Zn2+ 2017 chelation by serum albumin improves hexameric ...

Albumin is dependent upon insulin for its production via increased gene expression. Insulin activation is dependent upon albumin accepting its cleaved zincs. Albumin and other zinc binders do not modify insulin release.

The importance of zinc in the insulin-albumin interrelationship in MedNut Mail Albumin and the Zinc Switch

Albumin and Coagulation 

Early evidence indicates the Zinc Switch may be important in the coagulation cascade at injury sites. Evidence indicates excess zinc –

  • can bind to HRG which is a multi-function plasma protein that regulates coagulation;
  • increases turbidity which reflects the size and/or density of the clot formed. Fatty acid levels also correlate with turbidity.

Zinc Switch and Zinc Supplements 

Increased zinc binding to non-albumin plasma proteins may cause an apparent “mild zinc deficiency”. The initial research is based on coagulation responses in those with diabetes. However, a particular concern is the effects of zinc supplements when FA2 is fully occupied.

The proposed importance of the Zinc Switch in the coagulation cascade IN MedNut Mail Albumin and the Zinc Switch

Clinical Concerns 

Very limited evidence indicates fully occupied FA2 means the other 5 minerals bound to MBS-A are also excluded.

Stuff we really need to know–

   - the clinical significance of FA1 and FA7 allosteric impact on FA2, and MBS-A consequences;

   - identification of all the prescribed medicines, including their doses that directly impact FA2, FA1, FA7.

Allostery adds an extra layer of complexity, and interest, to albumin-based drug-nutrient interactions.

Clinical Questions

When you a review a person prescribed medicines that directly or indirectly affect the zinc switch, would you question -

  • whether they are altering albumin’s capacity to carry zinc and the other MBS-A-bound minerals thus altering their availability?
  • an apparent “mild zinc deficiency” and clarify adequacy of zinc intake before considering zinc supplements?

Conclusions

The zinc switch refers to an albumin-based drug-nutrient interaction mechanism involving zinc exchange. If the exchange does not proceed then outcomes include poor glycaemic control and likely altered coagulation.

Bibliography

Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties

Belinskaia, DA., Voronina, PA., Shmurak, VI., Jenkins, RO. & Goncharov, NV. 2021. Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties. International Journal of Molecular Science 22(19):10318. https://doi.org/10.3390/ijms221910318. PMID: 34638659; PMCID: PMC8508759.

Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin

Al-Harthi, S., Lachowicz, JI., Nowakowski, ME., Jaremko, M. & Jaremko, Ł. 2019. Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin. Journal of Inorganic Biochemistry 198:110716. https://doi.org/10.1016/j.jinorgbio.2019.110716. Epub 2019 May 20. PMID: 31153112.

The Five-To-Six-Coordination Transition of Ferric Human Serum Heme-Albumin Is Allosterically-Modulated by Ibuprofen and Warfarin: A Combined XAS and MD Study

Meneghini, C., Leboffe, L., Bionducci, M., Fanali, G., Meli, M., Colombo, G., Fasano, M., Ascenzi, P. & Mobilio, S. 2014. The Five-To-Six-Coordination Transition of Ferric Human Serum Heme-Albumin Is Allosterically-Modulated by Ibuprofen and Warfarin: A Combined XAS and MD Study. PLoS ONE 9(8): e104231. doi:10.1371/journal.pone.0104231

Reciprocal Allosteric Modulation of Carbon Monoxide and Warfarin Binding to Ferrous Human Serum Heme-Albumin

Bocedi, A., De Sanctis, G., Ciaccio, C., Tundo, GR., Di Masi, A., Fanali, G., Nicoletti, FP., Fasano, M., Smulevich, G., Ascenzi, P. & Coletta, M. 2013. Reciprocal Allosteric Modulation of Carbon Monoxide and Warfarin Binding to Ferrous Human Serum Heme-Albumin. PLoS ONE 8(3): e58842. doi:10.1371/journal.pone.0058842

Unraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential

Ashraf, S., Qaiser, H., Tariq, S., Khalid, A., Makeen, HA., Alhazmi, HA. & Ul-Haq, Z. 2023. Unraveling the versatility of human serum albumin - A comprehensive review of its biological significance and therapeutic potential. Current Research in Structural Biology 27(6):100114. https://doi.org/10.1016/j.crstbi.2023.100114. PMID: 38111902; PMCID: PMC10726258.

Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil

Liberi, S., Linciano, S., Moro, G., De Toni, L., Cendron, L. & Angelini, A. 2022. Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil. International Journal of Molecular Science 23:1769. https:// doi.org/10.3390/ijms23031769

Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties

Ascenzi, P., di Masi, A., Leboffe, L., Alberio, T., Fanali, G. & Fasano, M. 2013. Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties. IUBMB Life 65(6):544-549. https://doi.org/10.1002/iub.70030. Epub 2013 Apr 9. PMID: 23568641.

Enhanced hexamerization of insulin via assembly pathway rerouting revealed by single particle studies

Bohr, F., Bohr, SS., Mishra, NK., González-Foutel, NS., Pinholt, HD., Wu, S., Nielsen, EM., Zhang, M., Kjaergaard, M., Jensen, KJ. & Hatzakis, NS. 2023. Enhanced hexamerization of insulin via assembly pathway rerouting revealed by single particle studies. Communications Biology 6(1):178. https://doi.org/10.1038/s42003-022-04386-6. PMID: 36792809; PMCID: PMC9932072.

Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis

Pertusa, JAG., Leo´n-Quinto, T., Berna´, G., Tejedo, JR., Hmadcha, A., Bedoya, FJ., Franz Martın, F. & Soria, B. 2017. Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis. PLoS ONE 12(11):e0187547. https://doi.org/10.1371/journal.pone.0187547

Cite: Coleman, Y. 2025. Albumin and the zinc switch. MedNut Mail https://medicationsandnutrition.com/albumin-and-the-zinc-switch/  Accessed (date)

Albumin and the zinc switch

Professional Notice

The information in this article is designed to support healthcare professionals. It is not an exhaustive clinical protocol. Healthcare professionals are advised to maintain adequate professional supervision to ensure Duty of Care obligations with respect to safe administration of medicines is met for each individual consumer.

Core Philosophy

Whilst medications have profoundly improved global health outcomes, they typically also introduce nutritional challenges. By proactively identifying and addressing these nutritional harms, we can bridge the gap towards achieving better health outcomes.

MedNut Mail is a free fortnightlyish email that consists of an editorial - based on some aspect of PharmacoNutrition.

Icon for our MedNut Mail articles on drug-nutrient and drug-food

Want to make sure you do not miss any articles?

Then subscribe now and have it delivered to your inbox!

Malcare WordPress Security